Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008

Hepatitis

Free Subscription Articles published in J Hepatol Retrieve available abstracts of 199 articles: HTML format

Single Articles

May 2008
1. BURIONI R , Perotti M, Mancini N, Clementi M, et al
   Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugs.
   J Hepatol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. OVERBECK K , Genne D, Golay A, Negro F, et al
   Pioglitazone in chronic hepatitis C not responding to pegylated interferon-alpha and ribavirin.
   J Hepatol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. ZEUZEM S
   Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients.
   J Hepatol. 2008;.
   PubMed     Related articles   
   
   
   
4. DEUFFIC-BURBAN S , Deltenre P, Louvet A, Canva V, et al
   Impact of viral eradication on mortality related to hepatitis C: A modeling approach in France.
   J Hepatol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. LIBRA M , Gloghini A, Malaponte G, Gangemi P, et al
   In gastrointestinal mucosa-associated lymphoid tissue lymphomas t(14;18)-(IgH/Bcl-2) translocation clusters in hepatitis C virus-infected patients.
   J Hepatol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. JARDI R , Rodriguez-Frias F, Schaper M, Giggi E, et al
   Analysis of hepatitis B genotype changes in chronic hepatitis B infection: Influence of antiviral therapy.
   J Hepatol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. SHORES NJ , Maida I, Soriano V, Nunez M, et al
   Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.
   J Hepatol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   April 2008
8. BERNSMEIER C , Duong FH, Christen V, Pugnale P, et al
   Virus induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C.
   J Hepatol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. POTTHOFF A , Wedemeyer H, Boecher WO, Berg T, et al
   The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection.
   J Hepatol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. LAWITZ E , Rodriguez-Torres M, Muir AJ, Kieffer TL, et al
    Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. NGUYEN-KHAC E , Thevenot T, Piquet MA, Benferhat S, et al
    Antioxidants plus corticoids in the treatment of severe acute alcoholic hepatitis: The question is still open.
    J Hepatol. 2008;.
    PubMed     Related articles   
    
    
    
12. ANDRE P , Lotteau V
    Hepatitis C virus assembly: When fat makes it easier.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. STEWART S , Day CP
    Antioxidants plus corticoids in the treatment of severe acute alcoholic hepatitis: The question is still open: Reply.
    J Hepatol. 2008;.
    PubMed     Related articles   
    
    
    
14. FORTON DM , Hamilton G, Allsop JM, Grover VP, et al
    Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. DAI CY , Chuang WL, Ho CK, Hsieh MY, et al
    Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: A community-based study.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. BARTH H , Robinet E, Liang TJ, Baumert TF, et al
    Mouse models for the study of HCV infection and virus-host interactions.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
17. YATSUJI H , Suzuki F, Sezaki H, Akuta N, et al
    Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: Two-year follow-up.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. DEGERTEKIN B , Lok AS
    Monitoring antiviral resistance in patients receiving nucleos/tide analog therapies for hepatitis B: Which method should be used?
    J Hepatol. 2008;.
    PubMed     Related articles   
    
    
    
19. PEFFAULT DE LATOUR R , Ribaud P, Robin M, Valla D, et al
    Allogeneic hematopoietic cell transplant in HCV-infected patients.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    March 2008
20. FORNS X , Sanchez-Tapias JM, Bruguera M
    Nosocomial acquisition of the hepatitis C virus.
    J Hepatol. 2008;.
    PubMed     Related articles   
    
    
    
21. PUGNALE P , Herrmann E, Neumann AU, Pawlotsky JM, et al
    Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
22. DETERDING K , Wiegand J, Gruner N, Wedemeyer H, et al
    Medical procedures as a risk factor for HCV infection in developed countries: Do we neglect a significant problem in medical care?
    J Hepatol. 2008;.
    PubMed     Related articles   
    
    
    
23. LEVICNIK-STEZINAR S , Rahne-Potokar U, Candotti D, Lelie N, et al
    Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. KAPLAN DE , Ikeda F, Li Y, Nakamoto N, et al
    Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. BROERING R , Wu J, Meng Z, Hilgard P, et al
    Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    February 2008
26. JACOBSON IM
    Combination therapy for chronic hepatitis B: Ready for prime time?
    J Hepatol. 2008;.
    PubMed     Related articles   
    
    
    
27. SELZNER N , Chen L, Borozan I, Edwards A, et al
    Hepatic gene expression and prediction of therapy response in chronic hepatitis C patients.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
28. SUNG JJ , Lai JY, Zeuzem S, Chow WC, et al
    Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. KUROSAKI M , Matsunaga K, Hirayama I, Tanaka T, et al
    The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapy.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
30. VILLET S , Pichoud C, Billioud G, Barraud L, et al
    Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
31. BALDICK CJ , Eggers BJ, Fang J, Levine SM, et al
    Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
32. CACOUB P , Carrat F, Bedossa P, Lambert J, et al
    Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: The fibrovic study - ANRS HC02.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
33. RAIMONDO G , Navarra G, Mondello S, Costantino L, et al
    Occult hepatitis B virus in liver tissue of individuals without hepatic disease.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
34. LEROY V , Zarski JP
    Clinical applicability of non-invasive markers for liver fibrosis in chronic hepatitis C.
    J Hepatol. 2008;.
    PubMed     Related articles   
    
    
    
35. RODRIGUEZ-TORRES M , Govindarajan S, Sola R, Clumeck N, et al
    Hepatic steatosis in HCV/HIV co-infected patients: Correlates, efficacy and outcomes of anti-HCV therapy: A paired liver biopsy study.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
36. ZOULIM F , Perrillo R
    Hepatitis B: Reflections on the current approach to antiviral therapy.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
37. GAIA S , Barbon V, Smedile A, Olivero A, et al
    Lamivudine-resistant chronic hepatitis B: An observational study on adefovir in monotherapy or in combination with lamivudine.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
38. URBANI S , Amadei B, Tola D, Pedrazzi G, et al
    Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: Effect of viremia levels and antiviral treatment.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
39. MALLAT A , Hezode C, Lotersztajn S
    Environmental factors as disease accelerators during chronic hepatitis C.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
40. ROMERO-GOMEZ M , Fernandez-Rodriguez CM, Andrade RJ, Diago M, et al
    Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
41. LU JW , Wang H, Yan-Li J, Zhang C, et al
    Differential effects of pyrrolidine dithiocarbamate on TNF-alpha-mediated liver injury in two different models of fulminant hepatitis.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
42. POPOV Y , Patsenker E, Stickel F, Zaks J, et al
    Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
43. TAN J , Degertekin B, Wong SN, Husain M, et al
    Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
44. PURCELL RH , Emerson SU
    Hepatitis E: An emerging awareness of an old disease.
    J Hepatol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
45. GOETZ M , Vieth M, Kanzler S, Galle PR, et al
    In vivo confocal laser laparoscopy allows real time subsurface microscopy in animal models of liver disease.
    J Hepatol. 2008;48:91-7.
    PubMed     Related articles    Abstract available
    
    
    December 2007
46. VALENTI L , Dongiovanni P, Fargion S, Fracanzani AL, et al
    Iron genes, dysmetabolism and fibrosis in chronic hepatitis C.
    J Hepatol. 2007;.
    PubMed     Related articles   
    
    
    
47. THOMAS H
    Reply to "Definition of hepatitis B infection for the best practice in chronic disease and in immunosuppressed patients"
    J Hepatol. 2007;.
    PubMed     Related articles   
    
    
    
48. MARZANO A , Alessandria C, Rizzetto M
    Definition of hepatitis B infection for the best practice in chronic disease and in immunosuppressed patients.
    J Hepatol. 2007;.
    PubMed     Related articles   
    
    
    
49. LUPBERGER J , Brino L, Baumert TF
    RNAi - A powerful tool to unravel hepatitis C virus-host interactions within the infectious life cycle.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
50. REIJNDERS JG , Janssen HL
    Potency of tenofovir in chronic hepatitis B: Mono or combination therapy?
    J Hepatol. 2007;.
    PubMed     Related articles   
    
    
    
51. HUI CK , Zhang HY, Bowden S, Locarnini S, et al
    96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
52. TSUBOTA A , Yoshikawa T, Nariai K, Mitsunaga M, et al
    Bovine lactoferrin potently inhibits liver mitochondrial 8-OHdG levels and retrieves hepatic OGG1 activities in Long-Evans Cinnamon rats.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
53. EL-SERAG H , Kramer JR
    Hepatitis C infection: Dying with or from the infection?
    J Hepatol. 2007;.
    PubMed     Related articles   
    
    
    
54. SULKOWSKI MS
    Viral hepatitis and HIV coinfection.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
55. GIOVANNA F , Bortolotti F, Francesco D
    Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
56. VIDALI M , Tripodi MF, Ivaldi A, Zampino R, et al
    Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
57. SCHOLTES C , Diaz O, Icard V, Kaul A, et al
    Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
58. LOUVET A , Diaz E, Dharancy S, Coevoet H, et al
    Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
59. WASMUTH HE , Zaldivar MM, Berres ML, Werth A, et al
    The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
60. MARCELLIN P , Pequignot F, Delarocque-Astagneau E, Zarski JP, et al
    Mortality related to chronic hepatitis B and chronic hepatitis C in France: Evidence for the role of HIV coinfection and alcohol consumption.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
61. YAMAZAKI K , Suzuki K, Ohkoshi S, Yano M, et al
    Temporal treatment with interferon-beta prevents hepatocellular carcinoma in hepatitis B virus X gene transgenic mice.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
62. SCOTTA C , Garbuglia AR, Ruggeri L, Spada E, et al
    Influence of specific CD4+ T cells and antibodies on evolution of hypervariable region 1 during acute HCV infection.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
63. SZABO G , Dolganiuc A
    Hepatitis C core protein - The "core" of immune deception?
    J Hepatol. 2007;.
    PubMed     Related articles   
    
    
    
64. SULKOWSKI M
    Treatment of hepatitis C in HIV-infected persons: A work in progress.
    J Hepatol. 2007;.
    PubMed     Related articles   
    
    
    
65. ALTER MJ
    Healthcare should not be a vehicle for transmission of hepatitis C virus.
    J Hepatol. 2007;.
    PubMed     Related articles   
    
    
    
66. LIM YS , Oh HB, Choi SE, Kwon OJ, et al
    Susceptibility to type 1 autoimmune hepatitis is associated with shared amino acid sequences at positions 70-74 of the HLA-DRB1 molecule.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
67. ESTEBAN JI , Sauleda S, Quer J
    The changing epidemiology of hepatitis C virus infection in Europe.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
68. BERNAL W , Ma Y, Smith HM, Portmann B, et al
    The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study.
    J Hepatol. 2007;47:664-70.
    PubMed     Related articles    Abstract available
    
    
    October 2007
69. SCHMITZ KJ , Wohlschlaeger J, Lang H, Sotiropoulos GC, et al
    Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
70. TOYODA H , Kumada T, Kaneoka Y, Murakami Y, et al
    Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
71. AL-CHALABI T , Underhill JA, Portmann BC, McFarlane IG, et al
    Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
72. ZIMMERMANN M , Flechsig C, Monica NL, Tripodi M, et al
    Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
73. MARTI NEZ-BAUER E , Forns X, Armelles M, Planas R, et al
    Hospital admission is a relevant source of hepatitis C virus acquisition in Spain.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
74. BROWN RS JR
    Steroids in recurrent hepatitis C following liver transplantation: Pitfall or panacea?
    J Hepatol. 2007;.
    PubMed     Related articles   
    
    
    
75. CACOUB P , Halfon P, Rosenthal E, Pialoux G, et al
    Treatment of hepatitis C virus in human immunodeficiency virus infected patients in "real life": Modifications in two large surveys between 2004 and 2006.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
76. POUSTCHI H , Negro F, Hui J, Cua IH, et al
    Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
77. DI MARCO V , Craxi A
    Adefovir for lamivudine resistant HBV: more than meets the eye.
    J Hepatol. 2007;47:618-9.
    PubMed     Related articles   
    
    
    
78. DUFOUR JF
    NASH and thiazolidinediones: not to be taken lightly.
    J Hepatol. 2007;47:451-3.
    PubMed     Related articles   
    
    
    
79. GOODMAN ZD
    Grading and staging systems for inflammation and fibrosis in chronic liver diseases.
    J Hepatol. 2007;47:598-607.
    PubMed     Related articles    Abstract available
    
    
    
80. BORROTO-ESODA K , Miller MD, Arterburn S
    Pooled analysis of amino acid changes in the HBV polymerase in patients from four major adefovir dipivoxil clinical trials.
    J Hepatol. 2007;47:492-8.
    PubMed     Related articles    Abstract available
    
    
    
81. MAHESHWARI S , Sarraj A, Kramer J, El-Serag HB, et al
    Oral contraception and the risk of hepatocellular carcinoma.
    J Hepatol. 2007;47:506-13.
    PubMed     Related articles    Abstract available
    
    
    
82. KAMADA Y , Matsumoto H, Tamura S, Fukushima J, et al
    Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.
    J Hepatol. 2007;47:556-64.
    PubMed     Related articles    Abstract available
    
    
    September 2007
83. VIVARELLI M , Burra P, Barba GL, Canova D, et al
    Influence of steroids on HCV recurrence after liver transplantation: A prospective study.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
84. LAI M , Hyatt BJ, Nasser I, Curry M, et al
    The clinical significance of persistently normal ALT in chronic hepatitis B infection.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
85. DAL PERO F , Di Maira G, Marin O, Bortoletto G, et al
    Heterogeneity of CK2 phosphorylation sites in the NS5A protein of different hepatitis C virus genotypes.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
86. ZHANG Z , Zhang H, Chen D, Yao J, et al
    Favorable responsiveness to interferon-alpha treatment correlates with recovery of blood plasmacytoid dendritic cells in children with chronic hepatitis B.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
87. YANG F , Yan S, He Y, Wang F, et al
    Expression of hepatitis B virus proteins in transgenic mice alters lipid metabolism and induces oxidative stress in the liver.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
88. POON RT
    Significance of viral status on prognosis after resection of hepatitis B virus related hepatocellular carcinoma.
    J Hepatol. 2007;.
    PubMed     Related articles   
    
    
    August 2007
89. SUN HC , Zhang W, Qin LX, Zhang BH, et al
    Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
90. THOMAS HC
    Best practice in the treatment of chronic hepatitis B: A summary of the European Viral Hepatitis Educational Initiative.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
91. RAJENDRA A , Wong JB
    Economics of chronic hepatitis B and hepatitis C.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
92. MARCELLIN P , Heathcote EJ, Craxi A
    Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the 'accordion' regimen?
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
93. JENSEN GS , Trotter JF
    Treatment of chronic HCV in advanced liver disease: Unmet challenges, reason for optimism.
    J Hepatol. 2007;.
    PubMed     Related articles   
    
    
    
94. DEGOS F , Tural C
    Hepatocellular carcinoma in human immunodeficiency virus (HIV)-infected patients: Is it really different, and if so, why?
    J Hepatol. 2007;.
    PubMed     Related articles   
    
    
    
95. WATANABE T , Umehara T, Yasui F, Nakagawa SI, et al
    Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
96. ELINAV E , Pinsker G, Safadi R, Pappo O, et al
    Association between consumption of Herbalife((R)) nutritional supplements and acute hepatotoxicity.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
97. SCHOEPFER AM , Engel A, Fattinger K, Marbet UA, et al
    Herbal does not mean innocuous: Ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife((R)) products.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
98. MELUM E , Friman S, Bjoro K, Rasmussen A, et al
    Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
99. BRAU N , Fox RK, Xiao P, Marks K, et al
    Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.-Canadian multicenter study.
    J Hepatol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
100. HUANG YS , Su WJ, Huang YH, Chen CY, et al
     Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury.
     J Hepatol. 2007;47:128-34.
     PubMed     Related articles    Abstract available
     
     
     June 2007
101. DI MARCO V , Almasio PL, Ferraro D, Calvaruso V, et al
     Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension: A randomized controlled trial.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
102. MARCELLIN P , Horsmans Y, Nevens F, Grange JD, et al
     Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
103. RIVERA CA , Adegboyega P, van Rooijen N, Tagalicud A, et al
     Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
104. VELDT BJ , van der Vliet HJ, von Blomberg BM, van Vlierberghe H, et al
     Randomized placebo controlled phase I/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     May 2007
105. SCHULTHEISS M , Thimme R
     Toll like receptor 7 and hepatitis C virus infection.
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
106. BUTI M , Elefsiniotis I, Jardi R, Vargas V, et al
     Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
107. LARRUBIA JR , Calvino M, Benito S, Sanz-de-Villalobos E, et al
     The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
108. AHLENSTIEL G , Nischalke HD, Bueren K, Berg T, et al
     The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
109. BALAS B , Belfort R, Harrison SA, Darland C, et al
     Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
110. POCKROS PJ , Guyader D, Patton H, Tong MJ, et al
     Oral resiquimod in chronic HCV infection: Safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies>
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
111. STEWART S , Prince M, Bassendine M, Hudson M, et al
     A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis>
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
112. BURROUGHS AK , Cholongitas E
     Non-invasive tests for liver fibrosis: encouraging or discouraging results?
     J Hepatol. 2007;46:751-5.
     PubMed     Related articles   
     
     
     
113. STIENSTRA R , Mandard S, Tan NS, Wahli W, et al
     The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver.
     J Hepatol. 2007;46:869-77.
     PubMed     Related articles    Abstract available
     
     
     April 2007
114. RYDER SD
     Outcome of hepatitis C infection: Bleak or benign?
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
115. BENHAMOU Y
     Anemia and clinical outcomes in hepatitis C.
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
116. CHIN R , Earnest-Silveira L, Koeberlein B, Franz S, et al
     Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: Factors contributing to hepatocarcinogenesis.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
117. SOUVIGNET C , Maynard M, Gagnieu MC, Trepo C, et al
     Ribavirin in combination therapy for HCV chronic infection in HIV patients: How to win the war after winning the first battle?
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
118. WARD SM , Fox BC, Brown PJ, Worthington J, et al
     Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
119. LAI WK , Curbishley SM, Goddard S, Alabrabra E, et al
     Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
120. HUI CK , Zhang HY, Lee NP, Chan W, et al
     Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
121. SCHOTT E , Witt H, Neumann K, Taube S, et al
     A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
122. FAZLE AKBAR SM , Furukawa S, Yoshida O, Hiasa Y, et al
     Induction of anti-HBs in HB vaccine nonresponders in vivo by hepatitis B surface antigen-pulsed blood dendritic cells.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
123. HONDA Y , Yamagiwa S, Matsuda Y, Takamura M, et al
     Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosis.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
124. IANNACONE M , Sitia G, Ruggeri ZM, Guidotti LG, et al
     HBV pathogenesis in animal models: recent advances on the role of platelets.
     J Hepatol. 2007;46:719-26.
     PubMed     Related articles    Abstract available
     
     
     
125. GLUUD C , Brok J, Gong Y, Koretz RL, et al
     Hepatology may have problems with putative surrogate outcome measures.
     J Hepatol. 2007;46:734-42.
     PubMed     Related articles    Abstract available
     
     
     
126. BUENDIA MA
     Tumor suppressors in hepatocellular carcinoma: many are called, but few are chosen.
     J Hepatol. 2007;46:546-8.
     PubMed     Related articles   
     
     
     March 2007
127. CLEMENT S , Negro F
     Hepatitis C virus: The viral way to fatty liver.
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
128. SAMUEL D , Roche B
     Ribavirin in the treatment of recurrent hepatitis C after liver transplantation: Difficult to manage but essential for success.
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
129. GISH RG , Arora S, Reddy KR, Nelson DR, et al
     Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: A randomized, phase 2 study.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
130. BRUNETTO MR
     Tailoring antiviral therapy in chronic hepatitis B patients with Lamivudine resistance.
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
131. LAO TT , Chan BC, Leung WC, Ho LF, et al
     Maternal hepatitis B infection and gestational diabetes mellitus.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
132. LAWSON A , Hagan S, Rye K, Taguri N, et al
     The natural history of hepatitis C with severe hepatic fibrosis.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
133. FILLEBEEN C , Muckenthaler M, Andriopoulos B, Bisaillon M, et al
     Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     February 2007
134. DAHARI H , Markatou M, Zeremski M, Haller I, et al
     Early ribavirin pharmacokinetics, HCV RNA and alanine aminotransferase kinetics in HIV/HCV co-infected patients during treatment with pegylated interferon and ribavirin.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
135. BOSETTI C , Levi F, Lucchini F, Zatonski WA, et al
     Worldwide mortality from cirrhosis: An update to 2002.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
136. TARGHER G , Bertolini L, Padovani R, Rodella S, et al
     Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
137. FERENCI P , Ferenci S, Datz C, Rezman I, et al
     Morbidity and mortality in paid Austrian plasma donors infected with hepatitis C at plasma donation in the 1970s.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
138. WANG LY , Lin HH
     Ethnicity, substance use, and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
139. HEZODE C , Chevaliez S, Bouvier-Alias M, Roudot-Thoraval F, et al
     Efficacy and safety of adefovir dipivoxil 20mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10mg daily.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
140. ANGELICO M , Petrolati A, Lionetti R, Lenci I, et al
     A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
141. RENDINA M , Schena A, Castellaneta NM, Losito F, et al
     The treatment of chronic hepatitis C with peginterferon alfa-2a (40kDa) plus ribavirin in haemodialysed patients awaiting renal transplant.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
142. SILVA M
     Reply to issues raised in the Jansen/Reesink editorial.
     J Hepatol. 2007;46:350-1.
     PubMed     Related articles   
     
     
     
143. ZAMARA E , Galastri S, Aleffi S, Petrai I, et al
     Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice.
     J Hepatol. 2007;46:230-8.
     PubMed     Related articles    Abstract available
     
     
     
144. QIU J , Liu Z, Da L, Li Y, et al
     Overexpression of the gene for transmembrane 4 superfamily member 4 accelerates liver damage in rats treated with CCl4.
     J Hepatol. 2007;46:266-75.
     PubMed     Related articles    Abstract available
     
     
     January 2007
145. CARIANI E , Pelizzari AM, Rodella A, Gargiulo F, et al
     Immune-mediated hepatitis-associated aplastic anemia caused by the emergence of a mutant hepatitis B virus undetectable by standard assays.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
146. RODRIGUEZ-TORRES M , Rodriguez-Orengo JF, Rios-Bedoya CF, Fernandez-Carbia A, et al
     Effect of hepatitis C virus (HCV) treatment in fibrosis progression rate (FPR) and time to cirrhosis (TTC) in patients co-infected with human immunodeficiency virus (HIV): A paired liver biopsy study.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
147. LEROY V , Hilleret MN, Sturm N, Trocme C, et al
     Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
148. BORTOLOTTI F , Jorio R, Resti M, Camma C, et al
     Epidemiological profile of 806 Italian children with hepatitis C virus infection over a 15-year period.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
149. ROSENAU J , Kreutz T, Kujawa M, Bahr MJ, et al
     HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
150. ESMAT G , Metwally M, Zalata KR, Gadalla S, et al
     Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
151. REHERMANN B , Naoumov NV
     Immunological techniques in viral hepatitis.
     J Hepatol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
152. KUO A , Terrault NA
     Antiviral therapy in liver transplant recipients: Is SVR the only endpoint that matters?
     J Hepatol. 2007;.
     PubMed     Related articles   
     
     
     
153. GHOSE R , Mulder J, von Furstenberg RJ, Thevananther S, et al
     Rosiglitazone attenuates suppression of RXRalpha-dependent gene expression in inflamed liver.
     J Hepatol. 2007;46:115-23.
     PubMed     Related articles    Abstract available
     
     
     December 2006
154. VON HAHN T , McKeating JA
     In vitro veritas? The challenges of studying hepatitis C virus infectivity in a test tube.
     J Hepatol. 2006;.
     PubMed     Related articles   
     
     
     
155. CASTERA L , Denis J, Babany G, Roudot-Thoraval F, et al
     Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: Time for new guidelines?
     J Hepatol. 2006;.
     PubMed     Related articles   
     
     
     
156. VILLET S , Ollivet A, Pichoud C, Barraud L, et al
     Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
157. LAN KH , Lan KL, Lee WP, Sheu ML, et al
     HCV NS5A inhibits interferon-alpha signaling through suppression of STAT1 phosphorylation in hepatocyte-derived cell lines.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
158. KETTANEH A , Marcellin P, Douvin C, Poupon R, et al
     Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: A prospective study of 935 patients.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
159. VIDALI M , Occhino G, Ivaldi A, Serino R, et al
     Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     November 2006
160. SIERRA F
     Peginterferon alfa-2b vs. peginterferon alfa-2a in the treatment of hepatitis C, is there any difference?
     J Hepatol. 2006;.
     PubMed     Related articles   
     
     
     
161. NAVASA M , Forns X
     Antiviral therapy in HCV decompensated cirrhosis: To treat or not to treat?
     J Hepatol. 2006;.
     PubMed     Related articles   
     
     
     
162. JACKEL-CRAM C , Babiuk LA, Liu Q
     Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: Genotype-3a core has a stronger effect than genotype-1b core.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
163. EL-KAREF A , Kaito M, Tanaka H, Ikeda K, et al
     Expression of large tenascin-C splice variants by hepatic stellate cells/myofibroblasts in chronic hepatitis C.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
164. PICCIOTTO FP , Tritto G, Lanza AG, Addario L, et al
     Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
165. BONKOVSKY HL , Snow KK, Malet PF, Back-Madruga C, et al
     Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
166. MOUCARI R , Ripault MP, Oules V, Martinot-Peignoux M, et al
     High predictive value of early viral kinetics in retreatment with peginterferon and ribavirin of chronic hepatitis C patients non-responders to standard combination therapy.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
167. KREMER-TAL S , Narla G, Chen Y, Hod E, et al
     Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
168. ROST D , Welker A, Welker J, Millonig G, et al
     Liver-homing of purified glucose oxidase: A novel in vivo model of physiological hepatic oxidative stress (H(2)O(2)).
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
169. MOLINA S , Castet V, Fournier-Wirth C, Pichard-Garcia L, et al
     The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
170. DEMELIA L , Civolani A, Murgia D, Murru A, et al
     Tolerability of Peg interferon-alpha2b and Ribavirin therapy in patients with chronic hepatitis C and glucose-6-phosphate dehydrogenase deficiency.
     J Hepatol. 2006;.
     PubMed     Related articles   
     
     
     
171. GUYADER D , Thirouard AS, Erdtmann L, Rakba N, et al
     Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
172. LAU GK
     Does treatment with interferon-based therapy improve the natural history of chronic hepatitis B infection?
     J Hepatol. 2006;.
     PubMed     Related articles   
     
     
     
173. RAIMONDO G , Pollicino T, Cacciola I, Squadrito G, et al
     Occult hepatitis B virus infection.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
174. AKUTA N , Suzuki F, Kawamura Y, Yatsuji H, et al
     Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholester
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
175. HALFON P , Bacq Y, De Muret A, Penaranda G, et al
     Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
176. DURANTEL D , Zoulim F
     Going towards more relevant cell culture models to study the in vitro replication of serum-derived hepatitis C virus and virus/host cell interactions?
     J Hepatol. 2006;.
     PubMed     Related articles   
     
     
     
177. KUMAR ACHARYA S , Kumar Sharma P, Singh R, Kumar Mohanty S, et al
     Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
178. MIGITA K , Maeda Y, Abiru S, Nakamura M, et al
     Polymorphisms of interleukin-1beta in Japanese patients with hepatitis B virus infection.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
179. SCHOTT E , Witt H, Hinrichsen H, Neumann K, et al
     Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infection.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
180. DELA PENA A , Leclercq IA, Williams J, Farrell GC, et al
     NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
181. PARK YN , Roncalli M
     Large liver cell dysplasia: a controversial entity.
     J Hepatol. 2006;45:734-43.
     PubMed     Related articles    Abstract available
     
     
     October 2006
182. ALY HH , Watashi K, Hijikata M, Kaneko H, et al
     Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
183. BRAZZOLI M , Crotta S, Bianchi A, Bagnoli F, et al
     Intracellular accumulation of hepatitis C virus proteins in a human hepatoma cell line.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
184. WARREN A , Bertolino P, Benseler V, Fraser R, et al
     Marked changes of the hepatic sinusoid in a transgenic mouse model of acute immune-mediated hepatitis.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
185. LIN SM , Yu ML, Lee CM, Chien RN, et al
     Interferon therapy in HBeAg positive chronic hepatitis reduces cirrhosis and hepatocellular carcinoma.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
186. GALUN E , Terrault NA, Eren R, Zauberman A, et al
     Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: Safety and antiviral activity.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
187. IACOBELLIS A , Siciliano M, Perri F, Annicchiarico BE, et al
     Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: A controlled study.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
188. ZHOU J , Lu L, Yuen MF, Lam TW, et al
     Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infection.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     September 2006
189. DJILALI-SAIAH I , Fakhfakh A, Louafi H, Caillat-Zucman S, et al
     HLA Class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
190. ZHANG JY , Megliorino R, Peng XX, Tan EM, et al
     Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
191. DETERDING K , Tegtmeyer B, Cornberg M, Hadem J, et al
     Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
192. DE LEDINGHEN V , Trimoulet P, Mannant PR, Dumas F, et al
     Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: Long-term follow-up of 196 patients (4535 patient-years).
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
193. MUROYAMA R , Kato N, Yoshida H, Otsuka M, et al
     Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
194. PERSICO M , Capasso M, Persico E, Masarone M, et al
     Interleukin-10 -1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     August 2006
195. JANSEN PL , Reesink HW
     Antiviral effect of peginterferon alfa-2b and alfa-2a compared.
     J Hepatol. 2006;45:172-3.
     PubMed     Related articles   
     
     
     June 2006
196. MISSALE G
     Early intrahepatic CD8 responses in HBV pathogenesis: A new piece of the puzzle.
     J Hepatol. 2006;.
     PubMed     Related articles   
     
     
     May 2006
197. SUNEETHA PV , Sarin SK, Goyal A, Kumar GT, et al
     Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease.
     J Hepatol. 2006;44:856-63.
     PubMed     Related articles    Abstract available
     
     
     February 2006
198. SPRENGERS D , Molen RG, Kusters JG, Man RA, et al
     Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans.
     J Hepatol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     November 2005
199. SCHORR O , Borel C, Trepo C, Zoulim F, et al
     Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytes.
     J Hepatol. 2005;.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: